News and reflections from the world of AI

    November 16, 2021

    Aiforia achieves CE-IVD mark for clinical PD-L1 AI model in lung cancer diagnostics

    Worldwide the most common cause of cancer mortality in 2020 was lung cancer, with an estimated 1.80 million deaths occurring¹. Fortunately immunotherapies are increasing in prominence and efficacy². A popular target for these novel therapeutics is PD-L1, a vital biomarker indicating cancer progression³. The calculation of PD-L1 presence in tumors is routinely used in clinical pathology as a ...
    Written by Aiforia
    September 23, 2021

    Aiforia Earns ISO 27001 Security Certification

    Aiforia has received ISO 27001 certification, the premier global standard for Information Security Management Systems. With this certification, Aiforia highlights its mission to maintain the highest standards for information security in its AI-assisted digital pathology products.
    Written by Aiforia
    September 16, 2021

    Aiforia Announces Closing of €17.5M Series B Funding Round

    HELSINKI, Sept 16, 2021 -- Aiforia, a software company providing AI-based solutions for clinical diagnostics and preclinical analysis to enable pathologists to translate medical images into diagnoses and discoveries with more efficiency and precision, announced today the completion of a €17.5M Series B funding round. The funding round is led by Epredia's UK entity, a subsidiary of PHC Holdings ...
    Written by Aiforia
    August 19, 2021

    Aiforia and CompuMed collaborate to enhance organ transplant pathology with AI

    CompuMed and its team of highly experienced physicians provide specialized diagnostic interpretations to their clients who need answers in high urgency situations. Organ Procurement Organizations (OPOs) which provide organs and tissue for transplant centers need critical information relating to for example pathology, cardiology, or radiology to improve donor management, decrease donor evaluation ...
    Written by Aiforia
    June 21, 2021

    Epredia and Aiforia announce partnership for global distribution of AI-powered pathology software

    Portsmouth, NH, USA, June 21, 2021 – Epredia, a global leader in precision cancer diagnostics, and Aiforia, a medical software company providing Artificial Intelligence (AI) based solutions for image analysis in pathology, have announced today that they have entered into a commercial distribution agreement for Aiforia’s comprehensive portfolio of workflow enhancing solutions which enable ...
    Written by Aiforia
    June 10, 2021

    Aiforia announces CE-IVD mark for AI-supported breast cancer diagnostics

    First-of-its kind diagnostic tool Aiforia today announced the CE-IVD Mark for the Aiforia® Clinical AI Model for Breast Cancer; Ki67, a widely used key biomarker in breast cancer diagnostics across pathology labs around the world. The AI Model is able to calculate Ki67 positive and negative cells in invasive areas of human breast tissue in whole slide images (WSI) as well as in specific areas — ...
    Written by Aiforia
    3 4 5 6 7